Access Insights Conference is the only event dedicated to the full spectrum of biopharma commercialization - from regulatory policy to strategy to execution. In a year defined by policy volatility, pricing pressure, and rising launch stakes, Access Insights bridges executive vision with the operational realities that determine financial performance and patient access.
Our expert-led sessions feature industry strategists, operators, finance leaders, and technologists delivering actionable insights tailored to your company’s size, portfolio mix, and commercialization model.
Date/time: October 19-21, 2026
Location: The Mayflower Hotel, Autograph Collection · Washington, D.C.
Who should attend?
Access Insights is built for commercial, operational, and financial leaders at pharmaceutical manufacturers. That includes C-suite executives, VPs, and the analysts and operators who run pricing, market access, government programs, gross-to-net, and commercial data. Expert-led sessions are tailored by company size and portfolio, so both pre-commercial and established manufacturers will get sessions matched to where they are.
What will the 2026 agenda cover?
This year, we'll have more industry speakers, thought leaders, ecosystem partners, industry veterans, practitioners, and technologists sharing their insights – and some fun along the way!
Monday, October 19 | Executive Summit
The Summit opens with a state-of-the-state address from IntegriChain CEO Josh Halpern and a celebration of IntegriChain's 20-year anniversary. Bill Roth, SVP of Consulting & Advisory, presents "The Great Re-Pricing," a look at the fragmenting market and its emerging payer realities. Executive panels follow on healthcare policy, market dynamics, pricing, and commercialization strategy.
Tuesday–Wednesday, October 20-21 | Expert Panels and Hot Topics
Expert panels address three industry shifts: navigating the regulatory landscape, the evolving three-payer economy, and how agentic AI and technology will support decision-makers.
Hot Topics
Pricing, Policy, and Reimbursement
Navigating healthcare policy shifts, transitioning from affordability programs, innovating gross-to-net (GTN) modeling, and managing IRA, 340B, MFP readiness, and state price transparency requirements.
Data and Technology
Applying AI and ML innovation, building the next generation of data architecture, master data management, and affordability controls, including where agentic AI fits in the commercial stack.
Business and Strategy
Optimizing net revenue access, navigating pre-commercialization decisions, building commercial data strategies, and portfolio optimization across the manufacturer lifecycle.
Speakers
Access Insights brings together IntegriChain leaders, industry veterans, ecosystem partners, and technologists.
Check out last year’s recap: